Like most websites Compliance in Practice uses cookies. In order to deliver a personalised, responsive service and to continually improve the site, we remember and store information about how you use it. This is done using simple text filters called cookies, which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Compliance in Practice.
Declaration of Payments is one of the larger challenges you face in 2012 and 2013. However, it does not have to be. We know from experience that there is not a one size fits all solution but there is a solution that meets the demands of your business; and our team is committed to your success. We all know why the industry is changing, if you would like help with how, what, when and where, feel free to contact us.
As the first globally focused pharmaceutical compliance support and development business, Compliance in Practice has gained insight that crosses borders. The terms Transparency, Aggregate Spend, Declaration of Payments, Bribery, Sunshine Act and many more are all incarnations of the same intent. You and many others like you face the same challenge. However, rather than search for the right solution in isolation you can engage with our global transparency team.
We understand the way you do business is specific to your organisation and the KOLs, HCPs and Patient Groups you interact with around the world. You can draw on our subject experts and technology experts with unique cross-border, cross-business and cross-function pharmaceutical compliance and transparency knowledge base. Our team will help you implement specific aggregate spend solution to meet your challenges.
For more information please call us direct on + 44 (0) 1373 475 531